Vascularized Bone Marrow Cellular Depletion or Discontinuity Abrogates Protection of Vascularized Composite Allografts in Nonhuman Primates
Buckingham, Evan B
Nam, Arthur J
Barth, Rolf N
PublisherWolters Kluwer Health
MetadataShow full item record
AbstractBackground: Vascularized composite allografts (VCA) have demonstrated good clinical outcomes dependent on chronic immunosuppression. Previous work by our group and others supports that cotransplanted vascularized bone marrow (VBM) as a component of VCA offers immunologic protection to prolong graft survival. We aimed to characterize the requirements and potential mechanisms of VBM-mediated protection of VCA by modifying grafts through various strategies. Methods: Experimental groups of mismatched cynomolgus macaque recipients received VCA transplants modified by the following approaches: heterotopic separation of the VCA and VBM components; T-cell depletion of either donor or recipient; irradiation of donor VCA; and infusion of donor bone marrow. All groups received standard immunosuppression with tacrolimus and mycophenolate mofetil. Results: Experimental modifications to donor, recipient, or graft all demonstrated short-graft survivals (31 d). Chimerism levels without bone marrow infusion were transient and minimal when detected and were not associated with prolonged survival. Donor bone marrow infusion increased levels of chimerism but resulted in alloantibody production and did not improve graft survival. Conclusions: VCA graft survival is significantly reduced compared with previously reported VCA with VBM transplants (348 d; P = 0.01) when the hematopoietic niche is removed, altered, or destroyed via irradiation, depletion, or topographical rearrangement. These experimental manipulations resulted in similar outcomes to VCA grafts without cotransplanted VBM (25 d). These data support the presence of a radiosensitive, T-cell population within the VBM compartment not reconstituted by reinfusion of bone marrow cells.
Rights/TermsCopyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15534
- Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.
- Authors: Barth RN, Rodriguez ED, Mundinger GS, Nam AJ, Ha JS, Hui-Chou H, Jones LS, Panda A, Shipley ST, Drachenberg CB, Kukuruga D, Bartlett ST
- Issue date: 2011 Jul
- Effect of the vascularized bone components on the survival of vascularized composite allografts.
- Authors: Chen J, Zhang D, Zhang T, Chen C, Song Y, Liu S, Su Y, Guo S
- Issue date: 2018 Apr
- Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
- Authors: Chang J, Graves SS, Butts-Miwongtum T, Sale GE, Storb R, Mathes DW
- Issue date: 2016 Dec
- Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.
- Authors: Mathes DW, Chang J, Hwang B, Graves SS, Storer BE, Butts-Miwongtum T, Sale GE, Storb R
- Issue date: 2014 Jul 27
- A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
- Authors: Chen B, Xu H, Corbin DR, Ildstad ST
- Issue date: 2012 Oct 15